Drilldown: Medicines
Appearance
Medicines > onset
:
Day 3 of dosing in trials; sustained through day 45
or
Postprandial glucose effect within days; HbA1c by 12 weeks
& halflife:
~5 h (caffeine) 
:
Day 3 of dosing in trials; sustained through day 45
or
Postprandial glucose effect within days; HbA1c by 12 weeks
& halflife:
~5 h (caffeine) 
Use the filters below to narrow your results.
There are no results for this report.

